Agonist News and Research

RSS
Can GLP-1 weight loss drugs protect your brain as you age?

Can GLP-1 weight loss drugs protect your brain as you age?

What happens to heart health when you stop taking GLP-1 drugs?

What happens to heart health when you stop taking GLP-1 drugs?

Tirzepatide's benefits for teens with obesity go beyond weight loss

Tirzepatide's benefits for teens with obesity go beyond weight loss

GLP-1 weight-loss drugs may change what you crave, not just how much you eat

GLP-1 weight-loss drugs may change what you crave, not just how much you eat

Study shows opposite synaptic mechanisms cause identical cognitive deficits

Study shows opposite synaptic mechanisms cause identical cognitive deficits

From simple ovulation treatments to IVF, how doctors choose the right approach

From simple ovulation treatments to IVF, how doctors choose the right approach

Norrin treatment prevents vision loss in diabetic rats

Norrin treatment prevents vision loss in diabetic rats

MIT researchers track muscle movement using tiny magnetic beads

MIT researchers track muscle movement using tiny magnetic beads

Semaglutide changes gut bacteria in rats beyond what eating less explains

Semaglutide changes gut bacteria in rats beyond what eating less explains

Semaglutide and teduglutide reduce immune-driven gut injury in mice

Semaglutide and teduglutide reduce immune-driven gut injury in mice

AI study of 101,000 patients links brown fat to heart and mental health

AI study of 101,000 patients links brown fat to heart and mental health

Losing weight is one thing. Keeping your muscle is another, experts say

Losing weight is one thing. Keeping your muscle is another, experts say

Understanding how neutrophil signaling pathways disrupt the human intestinal barrier

Understanding how neutrophil signaling pathways disrupt the human intestinal barrier

Doctors avoided two common words when talking about weight with patients

Doctors avoided two common words when talking about weight with patients

FDA approves new Parkinson’s drug pioneered by UVA scientists

FDA approves new Parkinson’s drug pioneered by UVA scientists

Combination therapy overcomes immunotherapy resistance in glioblastoma

Combination therapy overcomes immunotherapy resistance in glioblastoma

Tirzepatide cuts fat mass by 35% while preserving skeletal muscle

Tirzepatide cuts fat mass by 35% while preserving skeletal muscle

CBL-514 injection reduces visceral and subcutaneous fat in trials

CBL-514 injection reduces visceral and subcutaneous fat in trials

Real-world data reveals higher reported GLP-1 side effects in female patients

Real-world data reveals higher reported GLP-1 side effects in female patients

Study examines the real-world use of GLP-1 RA drugs in children and young people

Study examines the real-world use of GLP-1 RA drugs in children and young people

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.